Works by Park, Jeong‐Hyun

Results: 63
    1
    2
    3
    4
    5
    6

    A double‐blind, Randomized controlled trial on glucose‐lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase‐4 inhibitor therapy: REFIND study

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1800, doi. 10.1111/dom.14766
    By:
    • Ryang, Soree;
    • Kim, Sang Soo;
    • Bae, Ji Cheol;
    • Han, Ji Min;
    • Kwon, Su Kyoung;
    • Kim, Young Il;
    • Nam‐Goong, Il Seong;
    • Kim, Eun Sook;
    • Kim, Mi‐kyung;
    • Lee, Chang Won;
    • Yoo, Soyeon;
    • Koh, Gwanpyo;
    • Kwon, Min Jeong;
    • Park, Jeong Hyun;
    • Kim, In Joo
    Publication type:
    Article
    7

    Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study ( TROICA study)

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 635, doi. 10.1111/dom.12866
    By:
    • Ahn, Chang Ho;
    • Han, Kyung Ah;
    • Yu, Jae Myung;
    • Nam, Joo Young;
    • Ahn, Kyu Jeung;
    • Oh, Tae Keun;
    • Lee, Hyoung Woo;
    • Lee, Dae Ho;
    • Kim, Jaetaek;
    • Chung, Choon Hee;
    • Park, Tae Sun;
    • Kim, Byung Joon;
    • Park, Seok Won;
    • Park, Hyeong Kyu;
    • Lee, Kwang Jae;
    • Kim, Sang‐Wook;
    • Park, Jeong Hyun;
    • Ko, Kwan Pyo;
    • Kim, Chong Hwa;
    • Lee, Hyunjin
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.

    Published in:
    Journal of Diabetes Investigation, 2014, v. 5, n. 6, p. 701, doi. 10.1111/jdi.12201
    By:
    • Kim, Hye‐soon;
    • Kim, Doo‐man;
    • Cha, Bong‐soo;
    • Park, Tae Sun;
    • Kim, Kyoung‐ah;
    • Kim, Dong‐lim;
    • Chung, Choon Hee;
    • Park, Jeong‐hyun;
    • Jang, Hak Chul;
    • Choi, Dong‐seop
    Publication type:
    Article
    14
    15
    16
    17

    Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea.

    Published in:
    Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2022, v. 15, p. 1495, doi. 10.2147/DMSO.S334944
    By:
    • Kim, Hye Soon;
    • Yu, Jae Myung;
    • Jang, Hak Chul;
    • Choi, Eui Kwang;
    • Park, Jeong Hyun;
    • Shon, Ho Sang;
    • Chung, Choon Hee;
    • Park, Keun-Gyu;
    • Cho, Jae Hyoung;
    • Kim, Won;
    • Lee, Kyoung Hwa;
    • Lee, Jee Hyun;
    • Yoo, Soon Jib
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise.

    Published in:
    Diabetes/Metabolism Research & Reviews, 2015, v. 31, n. 3, p. 295, doi. 10.1002/dmrr.2613
    By:
    • Jung, Chang Hee;
    • Park, Cheol‐Young;
    • Ahn, Kyu‐Joeng;
    • Kim, Nan‐Hee;
    • Jang, Hak‐Chul;
    • Lee, Moon‐Kyu;
    • Park, Joong‐Yeol;
    • Chung, Choon‐Hee;
    • Min, Kyung‐Wan;
    • Sung, Yeon‐Ah;
    • Park, Jeong‐Hyun;
    • Kim, Sung Jin;
    • Lee, Hyo Jung;
    • Park, Sung‐Woo
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50